. CBP and P/CAF Acetylate HMG I(Y) (A) Shown on the top are the results of in vitro acetylation experiments using recombinant 6HisCBP HAT (300 ng) or P/CAF HAT (100 ng) enzymes incubated with HMG I or core histones (2 g each) in the presence of 26 pmol of 3 H-Acetyl-CoA. Acetylation was monitored by filter-binding assays. The bottom of the figure shows a similar assay (using the same amounts of enzyme and substrates), demonstrating that the only component of the enhanceosome that can be acetylated by CBP is HMG I. Evidence supporting the involvement of IRF-3 and IRF-7 in IFN␤ expression has been previously published (Lin et al., 1998; Wathelet et al., 1998; Yoneyama et al., 1998) . (B) Same as in (A) except that the in vitro acetylation reactions were analyzed by SDS PAGE followed by autoradiography. The (ϩ) sign indicates the materials added to each reaction. (C) CBP and HMG I form complexes in vivo. HeLa nuclear extracts were immunoprecipitated with either CBP or HMG I antibodies followed by Western blot analysis using the same antibodies. Lane 1, ␣CBP antibody precipitates CBP. Lane 2, ␣HMG I antibody coprecipitates CBP. Lane 3, ␣HMG I antibody precipitates HMG I. Lane 4, ␣CBP antibody coprecipitates HMG I. (D) Shown are acetyltransferase filter-binding assays using core histones (left) or HMG I (right) as substrates and the immunoprecipitates from (C) as enzymes. example, CBP/p300 can acetylate p53, resulting in an protein acetyltransferase assays using highly purified recombinant proteins. The HAT domains of CBP (aa enhancement of its DNA-binding activity, as well as 1098-1758) and P/CAF (aa 396-718), as well as all of the basal transcription factors such as TFIIE and TFIIF, alknown components of the IFN␤ enhanceosome, were though the role of this latter acetylation remains unexpressed in bacteria and purified to near homogeneity. known (Gu and Roeder, 1997; Imhof et al., 1997) . Figure 1A (lanes 1 and 3) shows that both CBP and Interestingly, the IFN␤ enhancer, which is sufficient P/CAF HAT domains acetylate core histones, in agreefor activation of transcription, is also sufficient for postment with previous experiments (Bannister and Kouzainduction turnoff, although the mechanism of this phe- rides, 1996; Ogryzko et al., 1996; Yang et al., 1996) . nomenon remains unknown (reviewed in Maniatis et al., Remarkably, both HAT proteins can also specifically 1992). Here, we show that CBP and the CBP-associated acetylate recombinant HMG I nearly as efficiently as factor P/CAF acetylate HMG I(Y) either in solution or in histones (lanes 2 and 4). Interestingly, none of the other the context of the enhanceosome. Acetylation of HMG components of the IFN␤ enhanceosome can be ace-I(Y) by CBP, but not by P/CAF, decreases its DNA-bindtylated by either the CBP or P/CAF HAT domains (Figure ing activity and results in enhanceosome destabilization 1A, bottom). In addition, HMG I-C can also be acetylated and disassembly. We show that enhanceosome destabiby CBP and P/CAF (data not shown). The specificity of lization is due to the inability of CBP-acetylated HMG the reaction was demonstrated by the fact that labeling I(Y) to maintain NF-B in the enhanceosome. We also of HMG I depends on the presence of both radioactive find that the different effects of CBP and P/CAF on Acetyl-CoA ( 3 H) and CBP or P/CAF in the reaction (Figure enhanceosome stability are due to the fact that distinct 1B, lanes 1 and 2 and 5 and 6, respectively), excluding lysine residues in the HMG I(Y) protein are acetylated the possibility of either HMG I autoacetylation or nonby each of these factors. Furthermore, recruitment into specific binding of labeled acetyl-CoA to HMG I. Thus, the enhanceosome of a CBP molecule bearing mutathe HMG I protein family [HMG I(Y) and HMG I-C] is a tions in its HAT domain or an HMG I molecule that cannot bonafide substrate for CBP and P/CAF acetyltransferbe acetylated by CBP prevents postinduction turnoff of ase activities. Importantly, this observation is consistent IFN␤ gene expression in vivo. Finally, we demonstrate with the fact that acetylation represents one of the promthat CBP and P/CAF HAT activities are both required inent posttranslational modifications of HMG I proteins for activation, whereas only CBP HAT activity is required in living cells (Bustin and Reeves, 1996) . for postinduction turnoff of IFN␤ expression.
To test whether HMG I and CBP interact in vivo, we carried out immunoprecipitation experiments using HeLa Results nuclear extracts treated with HMG I-or CBP-specific antibodies followed by Western blot analysis. Figure 1C 
CBP and P/CAF Acetylate HMG I(Y)
shows that the HMG I antibody coprecipitates CBP (lane To investigate whether recruitment of CBP and P/CAF 2) and that the CBP antibody coprecipitates HMG I (lane into the enhanceosome could lead to specific acetyla-4). Most importantly, the HMG I immunoprecipitate contains acetyltransferase activity as it acetylates both core tion of any of its components, we carried out in vitro Figure 2 . Identification of the Sites in HMG I Acetylated by CBP and P/CAF HAT Domains (A) The indicated GST fused deletions of HMG I (2 g) were incubated with 300 ng CBP HAT or 100 ng P/CAF HAT proteins in the presence of 26 pmol 3 H Acetyl-CoA. 100% acetylation of full-length HMG I (1-107) corresponds to 12,000 cpm for CBP HAT and 14,000 cpm for P/CAF HAT. (B) The same derivatives shown in (A) were acetylated by P/CAF HAT, separated by SDS PAGE, and detected by autoradiography. Some of the HMG I derivatives display anomalous electrophoretic mobility as previously noted (Yie et al., 1997) . (C) Comparative acetylation of peptides I and II (2 g each) by CBP HAT and P/CAF HAT as determined by filter-binding assays. P/CAF HAT acetylates both peptides I and II, whereas CBP HAT only acetylates peptide II. The position and sequence of the peptides are also indicated. (D) Peptide II (6 g) was incubated with CBP HAT (900 ng) or P/CAF HAT (300 ng) proteins in the presence of 78 pmol of 3 H Acetyl-CoA for 1 hr at 30ЊC. The peptide was purified and 50% was subjected to N-terminal sequencing. 20% of each cycle was counted for 3 H incorporation. The arrows indicate Lys-65 and -71 acetylated by CBP and P/CAF HAT domains, respectively. (E) Acetylation assays were performed as in Figure 2A using the indicated mutant HMG I derivatives (1 g) and either CBP (300 ng) or P/CAF HAT (100 ng) proteins. histones and HMG I ( Figure 1D ). Identical results were removes the region between the middle and the last basic repeats, significantly reduced acetylation by CBP, also obtained after cotransfecting both CBP-and HMG I-expressing plasmids into Drosophila Schneider cells whereas it did not significantly affect P/CAF-dependent acetylation (Figure 2A , line 4; Figure 2B , lane 9). Compar-(data not shown). Finally, in vitro GST protein-protein interaction experiments demonstrated that the associa-ison of the relative acetylation efficiencies of CBP and P/CAF revealed that the minimal region of HMG I that tion of CBP and HMG I is direct and that multiple regions of CBP (including the HAT domain) can independently can be efficiently acetylated by both HAT proteins spans aa 65-90, whereas the amino terminal 34 aa of HMG I contact HMG I (data not shown).
are acetylated by P/CAF only (Figures 2A and 2B ). Figures 2A and 2B also show that P/CAF can acetylate CBP and P/CAF Acetylate HMG I at Distinct Sites To map the CBP-and P/CAF-dependent HMG I acetyla-HMG I with lower efficiency at several additional sites spanning the center of the molecule. Thus, CBP and tion sites, we used a series of amino and carboxyl terminal deletions (Yie et al., 1997) of the protein that were P/CAF exhibit site specificity in acetylating HMG I. To verify the acetylation site preference between CBP expressed and purified to near homogeneity either as GST or His-6 fusions. These derivatives were used in in and P/CAF in HMG I, we synthesized two peptides spanning the P/CAF-specific amino terminal region (aa 6-31) vitro acetylation experiments and the 3 H-labeled proteins were visualized by autoradiography after SDS and the CBP-P/CAF common acetylation sites in HMG I (aa 64-89) ( Figure 2C , peptides I and II, respectively). PAGE electrophoresis or were quantitated by filter-binding assays. Figure 2A shows that deletion of the carboxyl Figure 2C demonstrates that peptide I is preferentially acetylated by P/CAF and not by CBP, whereas peptide terminal acidic tail and the last basic repeat did not affect either CBP-or P/CAF-dependent acetylation of II is acetylated by both CBP and P/CAF, as predicted from our deletion analysis. To determine whether CBP HMG I (lines 1-3). However, deletion to aa 65, which and P/CAF acetylate peptide II at the same lysine residues, the 3 H acetylated peptide was purified and subjected to amino terminal sequencing. Figure 2D shows that the 3 H incorporation levels for different positions varies between CBP and P/CAF acetylated peptide II. Specifically, CBP preferentially acetylates Lys-65 whereas P/CAF preferentially acetylates Lys-71 ( Figure 2D ). Furthermore, mutation of Lys-65 to Arg, in the context of the intact HMG I protein, abolishes CBP-dependent acetylation ( Figure 2E ) verifying the specificity of this acetylation site. However, mutation of Lys-71 to Arg did not affect P/CAF's ability to acetylate HMG I, which is consistent with the presence of multiple P/CAF-dependent acetylation sites as determined by our deletion analysis (Figure 2A ). Taken together, these results indicate that the acetyltransferase activities of CBP and P/CAF show substrate specificity in acetylating HMG I.
Acetylation of HMG I by CBP but Not by P/CAF Decreases Its Sequence-Specific DNA Binding and Disrupts the HMG I/NF-B Complex
The HMG I protein contains three basic repeats involved in DNA binding from the minor groove. We have previously shown that specific high-affinity DNA binding is mediated by the middle repeat in cooperation with either the first or last repeat depending on the nature of the binding site (Yie et al., 1997) . The recent three-dimensional structure of HMG I bound to PRDII has revealed that K65, but not K71, makes backbone contacts with of the IFN␤ gene activators on the enhancer. To investigate the consequences of HMG I acetylation on its ability to bind cooperatively with NF-B, we carried out EMSA the HAT domain of P/CAF does not affect the HMG I/NFexperiments using the PRDII/NRDI composite site as a B cooperative complex (lanes 7 and 8). The specificity probe under conditions where HMG I and NF-B bind of this phenomenon was further investigated by using cooperatively to the DNA. Figure 3B (lane 2) shows that an HMG I mutant (HMG Imut) bearing substitutions in when low concentrations of NF-B were used, no signifithe lysine residues acetylated by these HAT proteins. cant binding was observed. However, addition of HMG As shown in Figure 3B , HMG Imut forms a cooperative I to the reaction resulted in the formation of a highcomplex with NF-B (Lane 11; Yie et al., unpublished affinity cooperative complex (lane 3), a result that is data) that cannot be disrupted by CBP HAT activity (lane consistent with previous studies (Thanos and Maniatis, 14) . Therefore, acetylation of Lys-65 in HMG I by CBP 1992). Incubation of this complex with either the CBP correlates with the disruption of the HMG I/NF-B com-HAT domain alone or with Acetyl-CoA alone had no plexes. Finally, the inability of P/CAF's HAT activity to effect on its stability (lanes 4 and 5). Remarkably, the affect complex formation is consistent with the fact that HMG I/NF-B cooperative complex was disrupted when P/CAF acetylates Lys-71, which is not involved in proboth CBP HAT and Acetyl-CoA were added to the reactein-DNA or protein-protein interactions with NF-B (Yie tion (lane 6). This disruption can be attributed to CBP's acetylation site preference for K65 in HMG I because et al., unpublished data). Thus, the HAT activity of CBP The probe was run out of the gel to facilitate separation of the complexes. The amounts of proteins used were 6 ng NF-B, 80 ng ATF-2/cJun, 250 ng IRF-1, 25 ng HMG I, 300 ng CBP HAT, and 100 ng P/CAF HAT. Acetyl-CoA was used at 25 nmoles. (B) CBP and P/CAF HAT domains acetylate HMG I in the context of the enhanceosome. The enhanceosome assembly reaction was scaled up 10-fold, proteins were purified by precipitation with 25% TCA, and they were analyzed by SDS PAGE followed by autoradiography. As seen in lanes 2 and 5, CBP and P/CAF HAT domains, respectively, acetylate HMG I in the context of the enhanceosome. The gel was exposed for 3 weeks. (C) CBP does not disrupt enhanceosomes containing HMG Imut. The proteins used in each reaction are indicated at the top of the gel. The amounts are as in (A), except that 100 ng of HMG Imut were used in the reaction, since HMG Imut has lower DNA-binding affinity compared to wild-type HMG I (Yie et al., unpublished data) . (D) Shown are the results of in vitro transcription experiments with HeLa nuclear extracts using the IFN␤ CAT template either alone (basal level, lane 1) or in the presence of the enhanceosome (lane 2). In lanes 3 and 4, the enhanceosome was incubated with Acetyl-CoA alone or with CBP HAT alone followed by the addition of extract and NTPs. Lane 5, CBP HAT and Acetyl-CoA were added together followed by the addition of the extract and NTPs. Lanes 6-10 are the same as in lanes 1-5 except that the activator used was IRF-7 alone. Correctly initiated transcripts were identified and quantitated by primer extension using a CAT primer.
destabilizes the HMG I/NF-B complexes formed at
Following incubation with the enzymes, the enhanceosome components were purified and visualized by auto-PRDII.
radiography after SDS PAGE. Figure 4B demonstrates that both CBP and P/CAF can acetylate only HMG I in Acetylation of HMG I by CBP Disrupts the context of the enhanceosome (lanes 2 and 5). Thus, the IFN␤ Enhanceosome the different effects of CBP and P/CAF HAT activities on To investigate the consequences of HMG I acetylation enhanceosome stability are likely due to the differential by CBP and P/CAF HAT domains in the context of the lysine residues acetylated in HMG I. Figure 4C demonnatural IFN␤ enhanceosome, we carried out EMSA exstrates that destabilization of the enhanceosome correperiments where enhanceosomes containing either wildlates with acetylation of HMG I since enhanceosomes type or mutant HMG I protein were challenged with the containing the HMG Imut protein, which cannot be ace-CBP or P/CAF HAT activities. Figure 4A demonstrates tylated (data not shown), are not affected by the CBP that addition of HMG I to a low amount of IFN␤ activators HAT activity (compare lane 3 with 9). promoted the assembly of the enhanceosome (compare To test whether the CBP HAT activity can disrupt a lanes 1 and 2). The amount of HMG I used was detertranscriptionally active enhanceosome, we carried out in mined in separate experiments to ensure that there was vitro transcription experiments. Under these conditions no free HMG I protein in the reaction (data not shown).
(low activator concentration), addition of HMG I is abso-Incubation of these enhanceosomes with either CBP lutely required for enhanceosome assembly and activa-HAT or Acetyl-CoA separately did not have any effect tion of transcription (Kim and Maniatis, 1997 ; Yie et al., on their stability (lanes 3 and 4) . However, enzyme and unpublished data). Figure 4D shows that assembly of the Acetyl-CoA added together significantly decreased enenhanceosome in vitro leads to high levels of activated hanceosome stability (lane 5). Interestingly, along with transcription (compare lanes 1 and 2). Incubation of the fully assembled enhanceosome, all partial enhanceothese enhanceosomes with CBP HAT or Acetyl-CoA somes containing NF-B were also destabilized. In alone did not have a significant effect on the amount of sharp contrast, the P/CAF HAT activity did not affect transcription (lanes 3 and 4) . However, addition of both enhanceosome stability (lanes 6 and 7) .
CBP HAT and Acetyl-CoA to the reaction strongly inhib-To directly demonstrate that both CBP and P/CAF ited transcription (lane 5). This effect is specific to the HAT domains can acetylate HMG I in the context of the enhanceosome since neither the activation of the IFN␤ enhanceosome, we scaled up the assembly reaction 10fold and replaced cold Acetyl-CoA with 3 H Acetyl-CoA.
promoter by IRF-7 alone ( Figure 4D, lanes 6-10) nor the gradually decreases and finally reaches the basal uninduced level at 48 hr post infection. Cotransfection of an expression vector encoding wild-type CBP or P/CAF proteins further stimulated the transcriptional activity of the enhanceosome, with no effect on the kinetics of virus-induced transcription. Thus, in both cases, the virus-inducible expression reached the basal (uninduced) level by the end of the time course ( Figure 5A ). To investigate the role of the HAT activities, we transfected derivatives containing two amino acid substitutions in the Acetyl-CoA-binding site of either CBP or P/CAF. It has been previously demonstrated that these derivatives (CBP HAT Ϫ and P/CAF HAT Ϫ ) lack HAT activity (Korzus et al., 1998 ; Figure 5B ). We demonstrate here that these mutant HAT proteins also lack the ability to acetylate HMG I in vitro ( Figure 5B ). Remarkably, transfection of the CBP HAT Ϫ expression vector altered the kinetics of virus-induced transcription from the IFN␤ enhanceosome by preventing postinduction turnoff. Importantly, the levels of activated transcription obtained with CBP HAT Ϫ were lower compared to wild-type CBP ( Figure  5A ). Thus, the HAT activity of CBP is required for both optimum activation and postinduction turnoff of IFN␤ gene expression. In contrast, the P/CAF HAT activity is only required for optimum activation of transcription with no effect on postinduction turnoff ( Figure 5A ). To investigate whether these effects are due to specific acetylation of HMG I by CBP in the context of the enhanceosome, we carried out transfection experiments the postinduction turnoff mechanisms. The role of CBP's HAT activity in this process was revealed by showing that enhanceosomes bearing either wild-type HMG I basal levels of transcription is affected (data not shown). and CBP HAT Ϫ or wild-type CBP and HMG Imut are Thus, acetylation of HMG I by CBP specifically disrupts incapable of postinduction shutoff of IFN␤ transcription transcriptionally active enhanceosomes.
( Figure 6A ). Taken together, these experiments strongly support the notion that there is a direct correlation be-The CBP HAT Activity Is Required for Postinduction tween the ability of CBP to specifically acetylate HMG Turnoff of IFN␤ Expression I and postinduction turnoff of IFN␤ gene expression. We have previously shown that recruitment of CBP into Additional evidence for the functional interplay bethe enhanceosome is required for virus-induced trantween CBP HAT activity and HMG I in the context of scription from the IFN␤ promoter (Merika et al., 1998) .
the IFN␤ enhanceosome was provided by transfection However, here we show that when CBP is recruited experiments in Drosophila Schneider cells. Figure 6B into the enhanceosome, it also can acetylate HMG I, demonstrates that transfection of wild-type HMG I poresulting in enhanceosome destabilization. These contentiates enhanceosome formation and transcription tradictory observations led us to the hypothesis that from the IFN␤ promoter (compare lanes 5 and 6), and CBP's HAT activity may be involved in turning off IFN␤ these levels were further enhanced (‫-5.2ف‬fold) by cogene expression. To address this, we carried out transtransfecting CBP (lane 7). Figure 6B (lane 8) demonfection experiments in COS cells where the transcripstrates that transfection of HMG Imut also facilitated tional activity of the IFN␤ promoter was monitored at enhanceosome assembly, albeit to a lower extent. Interdifferent times following virus infection. Figure 5A demestingly, the HMG Imut-containing enhanceosomes are onstrates that the transfected IFN␤ promoter is trancoactivated by CBP (‫-8ف‬fold) to significantly higher levsiently activated by virus infection, mimicking the overall els compared to enhanceosomes bearing wild-type pattern of activation of the endogenous gene (Maniatis HMG I (compare lanes 6 and 7 with 8 and 9). Since HMG et al., 1992). As seen in the figure, expression levels Imut containing enhanceosomes cannot be destabilized by CBP HAT activity ( Figures 4C and 6A) , we conclude peak at 16 hr post infection. After that time, transcription for Proper Kinetics of IFN␤ Virus Induction or HMG Imut (1 g) in the absence or the presence of the indicated (A) COS cells were transfected as in Figure 5 with the indicated CBP derivatives (2 g). The cells were induced for the indicated expression vectors. CBP P/CAF HAT refers to a CBP expression vector time, and the CAT activity was determined and plotted as fold virus bearing the P/CAF HAT domain in place of that of CBP. Accordingly, induction. P/CAF CBP HAT refers to a P/CAF expression vector bearing the CBP (B) Drosophila Schneider cells were cotransfected with a CAT re-HAT domain in place of that of P/CAF. porter (200 ng) bearing the IFN␤ gene enhancer cloned upstream (B) Comparison of the effects of cotransfecting wild-type CBP and of the ADH TATA box, along with expression vectors encoding the P/CAF or HAT domain swap CBP and P/CAF chimeras. indicated proteins. The amounts of expression vectors used were 100 ng of an equimolar mixture of pPAC p50 and pPAC p65, 800 ng of pPAC IRF-1, 600 ng of an equimolar mixture of pPAC ATF-2 7A). However, recruitment of this chimera into the enand pPAC c-JUN, 600 ng of pPAC HMG I or pPAC HMG Imut, and hanceosomes resulted in a strikingly earlier onset of 1 g of pPAC CBP. The total amount of transfected DNA was brought to 4 g by adding pPAC vector as necessary. transcriptional activation. A dramatic illustration of this is the amount of transcription obtained at 6 hr post infection ( Figure 7A ). Finally, cotransfection of both chimeric proteins did not affect either the kinetics of ex-that the higher activity of these enhanceosomes in vivo is due to their increased stability. These results, taken pression or the levels of transcription when compared to cotransfection of the wild-type counterparts (Figure together with our other experiments, strongly suggest that the HAT activity of CBP potentiates transcription, 7B). Taken together, these experiments strongly suggest that the P/CAF and CBP HAT activities per se, as perhaps by acetylation of histones, but equally importantly, acetylation of HMG I by CBP results in enhance-well as their geometry within the enhanceosome, are interchangeable for activation of transcription. However, osome destabilization and therefore termination of transcription.
the CBP HAT activity is also required for postinduction turnoff of IFN␤ transcription by acetylating HMG I. Thus, Further evidence for the distinct in vivo roles of CBP and P/CAF HAT activities was provided by the use of the timing of virus-dependent IFN␤ gene expression in vivo is regulated by the distinct functional properties of chimeric CBP and P/CAF proteins containing their HAT domains interchanged. Figure 7A shows that substitu-CBP and P/CAF HAT activities. tion of CBP's HAT domain with P/CAF's HAT domain completely prevented transcriptional postinduction turnoff Discussion (CBP P/CAF HAT construct). On the other hand, replacement of P/CAF's HAT domain with that of CBP (P/CAF CBP HAT In this paper, we have examined the functions of the CBP and P/CAF coactivators subsequent to their recruitment construct) did not affect postinduction turnoff (Figure into the IFN␤ gene enhanceosome. Both CBP and P/CAF a distinction between the HAT activities of CBP and P/CAF. It appears that the substrate specificity between acetylate HMG I(Y), the essential architectural component for the assembly and stability of the enhance-CBP and P/CAF HAT activities in acetylating HMG I provides the molecular basis for their distinct roles in osome. Moreover, the lysine residues in HMG I(Y) acetylated by CBP and P/CAF differ, and this difference the activity and fate of the IFN␤ gene enhanceosome. However, it is possible that acetylation of HMG I by accounts for their distinct effects on the fate of transcription. More specifically, HMG I K65, which is acetylated P/CAF may affect its DNA-binding activity on other promoters or its association with other transcription factors. by CBP, is critical for high-affinity binding to DNA, whereas K71, which is acetylated by P/CAF, is not. In
In addition, other HAT proteins may also acetylate HMG I and influence its activity. Finally, the in vivo association addition, in the context of the enhanceosome, acetylation of HMG I by CBP, but not by P/CAF, leads to of HMG I with the CBP-P/CAF complex may also influence its interaction or activity with several other cellular enhanceosome destabilization and disassembly. Furthermore, we have established a biologically relevant or viral (e.g., E1A) regulators. function in vivo for the acetylation of a non-histone protein by showing that the HAT activity of CBP on HMG I The IFN␤ Enhanceosome Is a "Time Bomb" is essential for turning off IFN␤ gene expression. Finally,
The discovery of enhanceosomes provided the first the distinct functional properties of CBP and P/CAF compelling mechanistic basis for explaining the phe-HAT activities fine tune the timing of virus-dependent nomenon of transcriptional synergy in natural promoters activation of the IFN␤ gene. and enhancers (reviewed in Carey, 1998). Thus, the extraordinary stability of the IFN␤ enhanceosome, along with its abilities to recruit CBP and to simultaneously HMG I Proteins Are Bonafide Substrates for CBP and P/CAF Acetyltransferase Activity contact several components of the basal machinery, ensures high levels of activated transcription. However, A large body of previous studies have established that the HMG I proteins function as pleiotropic regulators the IFN␤ gene is only transiently activated, implying that transcription driven by the enhanceosome must be ter-in the cell. For example, HMG I proteins regulate the expression of a large number of genes such as cyto-minated. In principle, this can be accomplished by mechanisms that allow transient formation of the en-kines, cell adhesion molecules, growth factors, transcription factors, and viral gene products (Bustin and hanceosome followed by recruitment of repressors and corepressors to maintain shutoff of transcription. Previ-Reeves, 1996) . The commonality of these diverse regulatory functions lies in the HMG I family's remarkable prop-ous studies have established that virus infection induces the synthesis of several proteins that can function as erties of interacting with many different transcription factors and binding and altering the structure of DNA inhibitors of IFN␤ gene expression. Among these are DNA-binding proteins (with no activation potential) that in a way that facilitates assembly of functional higher order nucleoprotein complexes (Thanos and Maniatis, may directly compete for binding to the enhancer (e.g., IRF-2, PRDI-BF1, PRDII-BF1, and p50 homodimers) as 1995a). Thus, it is not surprising that disruption of the HMG I genes directly correlates with tumorigenesis and well as proteins that inhibit NF-B, such as IkB␣ (Maniatis et al., 1992; Thanos and Maniatis, 1995b ; Tran et that a null mutation of HMG I-C in mice decreases the rate of cell proliferation, resulting in the pygmy pheno-al., 1997) . However, none of the above mentioned DNAbinding proteins possesses a DNA-binding affinity sig-type Zhou et al., 1995) . Similar to HMG I, CBP/p300 is also a pleiotropic regulator. CBP/ nificant enough to disrupt the enhanceosome by competition, nor can IkB␣ remove NF-B in the context of the p300 interacts with a diverse collection of transcription factors and participates in a broad spectrum of biologi-enhanceosome (our unpublished data). Instead, as we demonstrate here, the enhanceosome contains all of the cal activities. However, the mode of CBP's action differs from that of HMG I. Most likely, CBP is recruited to necessary information for self destruction. The driving force for enhanceosome disassembly appears to be the already preformed enhanceosomes and thereafter modulates their transcriptional properties (Merika et al., inability of K65-acetylated HMG I to maintain NF-B on DNA. Remarkably, this effect is specific for NF-B 1998). Again, disruption of the CBP/p300 genes causes severe global developmental abnormalities (Petrij et al., because acetylation of HMG I by CBP does not affect its ability to form cooperative complexes with ATF-2/ 1995; Yao et al., 1998) . Therefore, our demonstration that CBP alters the DNA-binding affinity of HMG I by cJun at PRDIV (data not shown). Thus, perhaps acetylation of HMG I initially destabilizes the enhanceosome at acetylation provides an important means for the integration and interpretation of multiple signal transduction PRDII (NF-B and HMG I binding site) and subsequently detachment of NF-B and HMG I mediate its disruption. pathways. For genes whose expression is positively affected by HMG I proteins, for example, CBP-dependent
The reason for these differential effects of HMG I at PRDII and PRDIV could be due to the dual role of HMG acetylation of HMG I could lead to termination of transcription, as is the case for IFN␤. By contrast, for genes I at PRDII. Thus, binding of HMG I at PRDII not only counteracts an unfavorable intrinsic DNA bend allowing negatively regulated by HMG I, the same acetylation events may facilitate their activation. Thus, the func-stable binding of NF-B to the site but is also required to relieve the stereospecific clashes between NF-B and tional linkage between these two global and pleiotropic regulators could generate and fine tune multiple expres-IRF proteins bound at the nearby PRDI element (Falvo et al., 1995; Thanos and Maniatis, 1995a ; Escalante et sion and developmental programs.
HMG I is the only known substrate for which there is al., 1998). Furthermore, since the middle basic repeat of HMG I is its high-affinity DNA-binding domain, ace-contrast, the second model predicts that the choice for CBP to acetylate histones or HMG I is stochastic. Thus, tylation of K65 provides a simple and elegant mechanism to significantly decrease its ability to bind DNA. a significant number of initially formed enhanceosomes will be disrupted before they activate transcription be-Thus, a weakening of the HMG I-DNA interactions by cause CBP may acetylate HMG I first. Consistent with acetylation suffices for enhanceosome disruption.
this idea is the observation that only a fraction of virus-Our experiments, taken together with previous studinfected cells are induced to express IFN␤ (Maniatis ies, are consistent with the following model for activation et al., 1992) . Thus, it is conceivable to assume that in and postinduction shutoff of IFN␤ gene expression. Vinonexpressing cells, the enhanceosomes formed at the rus infection causes the coordinate activation of multiple onset of virus infection have been disrupted because transcriptional activator proteins (NF-B, ATF-2/cJun, CBP acetylates HMG I first. The rest of the cells tran-IRFs) that, in the presence of HMG I, bind cooperatively scribe IFN␤ because CBP acetylates histones first. Actiand form the enhanceosome on the IFN␤ enhancer vated transcription continues until CBP acetylates HMG (Thanos and Maniatis, 1995a) . As a result of enhanceo-I, thus leading to enhanceosome disruption. Perhaps some assembly, the activation domains of the activators most or all of the disrupted enhanceosomes do not create a novel activating surface that, in turn, recruits reassemble because of the appearance in the nucleus CBP and CBP-associated proteins or complexes (e.g., of newly synthesized repressors (mentioned above) that P/CAF, polII holoenzyme, etc.) (Merika et al., 1998) . Sibind to the IFN␤ promoter and of the ability of newly multaneously, the activation domains also establish synthesized IkB␣ to enter the nucleus, to associate with contacts with other components of the basal machinery NF-B, and to thus prevent its DNA binding (Tran et al., (e.g., TFIID, TFIIA, TFIIB, USA, etc.) (Kim and Maniatis, 1997) . Therefore, we propose that the acetylation of 1998). Access of the basal machinery to the promoter HMG I by CBP shifts the dynamic equilibrium of IFN␤ may be facilitated by the HAT activities of CBP and transcription from activation towards repression. P/CAF via acetylation of histones in nearby nucleosomes. In fact, we have shown that the HAT activities HAT or P/CAF HAT domains stimulate transcription at similar levels ( Figure 7A ). Thus, we imagine that the Recombinant Protein Purification acetylation targets of these domains might be either the GST-HMG I fusions were expressed and purified as described presame or related. The difference in the onset of gene viously (Yie et al., 1997) . His-6-fused proteins were purified on a nickel column under native conditions as suggested by the manufac-activity between these enhanceosomes could be the turer (Qiagen) except that the binding buffer used contained 10 mM result of the relative efficiency or rate by which the HAT Tris Cl [pH 8.0], 10% glycerol, 500 mM NaCl, 0.1% NP-40, 10 mM proteins acetylate their targets. Another important con-␤-mercaptoethanol, 1 mM PMSF, 10 mM imidazole, 1 g/ml leupepclusion from these experiments is that the geometry of tin, and 1 g/ml aprotinin. the HAT domains in the context of the enhanceosome is not critical for their function. However, this latter ob-Acetyltransferase Assays Acetyltransferase assays were essentially carried out as previously servation contrasts with the spatial specificity required described (Gu and Roeder, 1997) . A typical reaction was performed for recruiting the coactivators into the enhanceosome in a volume of 30 l containing 1-2 g highly purified recombinant (Merika et al., 1998) . protein, 300 ng CBP HAT or 100 ng P/CAF HAT, 26 pmol 4.8 Ci/mmol The demonstration that the CBP HAT activity plays a 3 H-Acetyl-CoA (Amersham), and a standard buffer (10% glycerol, 50 role in both transcriptional activation and postinduction mM HEPES [pH 8.0], 1 mM DTT, 1 mM PMSF, and 10 mM sodium butyrate) at 30ЊC for 1 hour. Filter-binding assays and gel assays turnoff is intriguing. For example, what prevents CBP were performed as described previously (Gu and Roeder, 1997) . from acetylating HMG I immediately after its recruitment into the enhanceosome, thereby leading to its disrup-
Mapping of HMG I Acetylation Sites
tion? We imagine two different models to explain this Peptides corresponding to two portions of HMG I (peptide I, aa puzzle. In the first, due to the enhanceosome context, 6-31; peptide II, aa 64-89) were synthesized and purified by HPLC to CBP may acetylate HMG I with lower efficiency and 95% purity. The peptides were used in a standard acetyltransferase reaction and thereafter subjected to N-terminal microsequencing in rate compared to its other targets (e.g., histones), thus which 20% of each cycle was used to determine 3 H-Acetyl-CoA allowing activation of transcription. Alternatively, the incorporation, and the rest was used for amino acid identification. substrate specificity of CBP's HAT activity may be regulated by posttranslational modifications or by other co-Electrophoretic Mobility Shift Assays and In Situ Acetylation factors synthesized after virus infection. Therefore, after DNA-binding reactions with the appropriate amounts of proteins histones or other targets have been acetylated, CBP (indicated in figure legends) and DNA probe were mixed and incubated in 15% glycerol, 10 mM HEPES (pH 8.0), 10 mM Tris Cl (pH acetylates HMG I and disrupts the enhanceosome. In 8.0), 15 mM NaCl, 10 mM Na butyrate, 2 mM DTT, 2 mM PMSF, E.M., Mullen, T.-M., Glass, C.K., and Rosenfeld, M.G. (1998) . Transcription factor-specific requirements for coactivators and their ace-0.05% NP-40, 1 mg/ml BSA, and 50 ng pdG-dC for 15 min at room tyltransferase functions. Science 279, 703-707. temperature. For EMSA's involving in situ acetylation, DNA-binding reactions were challenged with CBP HAT or P/CAF HAT and cold Kurokawa, R., Kalafus, D., Ogliastro, M.-H., Kioussi, C., Xu, L., Acetyl-CoA for 90 min at room temperature. Protein-DNA complexes Torchia, J., Rosenfeld, M.G., and Glass, C.K. (1998) . Differential were subsequently resolved by electrophoresis as previously deuse of CREB binding protein-coactivator complexes. Science 279, scribed (Merika et al., 1998) . 700-703.
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